Effects of taking Fulvestrant after one year

The results after one year of taking Fulvestrant (Fulvestrant) may vary from person to person. Normally, fulvestrant plays an anti-estrogenic role in breast cancer treatment, helping to block tumor cells' dependence on estrogen, thereby inhibiting tumor growth and spread. During one year of treatment, fulvestrant may slow or stop the progression of breast cancer, causing tumors to shrink or stabilize. Treatment results can be affected by many factors, including the type and stage of breast cancer and the individual's overall health. It’s important to note that each person’s response to treatment is unique. For specific conditions and treatment plans, doctors will evaluate the patient's situation and provide more detailed information and guidance.